We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 02, 2021

Recurrence- and Progression-Free Survival in Intermediate-Risk Non–Muscle-Invasive Bladder Cancer

BJU International


Additional Info

Disclosure statements are available on the authors' profiles:

BJU International
Recurrence- and Progression-Free Survival in Intermediate-Risk Non-Muscle-Invasive Bladder Cancer: The Impact of Conditional Evaluation and Subclassification
BJU Int 2021 Apr 01;127(4)473-485, Y Kohada, T Hayashi, RS Hsi, K Yukihiro, K Sentani, K Goto, S Inoue, S Ohara, J Teishima, M Kajiwara, T Nishisaka, W Yasui, PC Black, A Matsubara

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading